Immunic, Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Immunic, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-06-30 was $0.00.
- Immunic, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-09-30 was $282.00K.
- Immunic, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-03-31 was $51.00K, a 99.83% decline year-over-year.
- Immunic, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2022-06-30 was $9.95M.
- Immunic, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $51.00K.
- Immunic, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2019 was $37.19M.
- Immunic, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2014 was $110.80M.
- Immunic, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2012 was $54.72M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2025-06-30 | $0.00 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $51.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $282.00K 10-Q · filed 2023-11-14 | |
| 2023-03-31 | $51.00K 10-Q · filed 2024-11-07 | |
| 2022-06-30 | $9.95M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $29.64M 10-Q · filed 2023-11-14 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $37.19M 10-K · filed 2021-02-26 |
| 2019-06-30 | $37.19M 10-Q · filed 2020-11-06 | |
| 2014-12-31 | $110.80M 10-K · filed 2017-03-07 | |
| 2012-12-31 | $54.72M 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B |